Serial Number | 97759944 |
Word Mark | PAPIVAX |
Filing Date | Wednesday, January 18, 2023 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, February 6, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, February 6, 2024 |
Description of Mark | The mark consists of stylized wording "PapiVax". On the left, there is a globe with rings and orbits and three viruses made up of nine groups of parallel lines, two incomplete circles, and wavy outline. |
Name/Portrait Description and/or Consent Statement | The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual. |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Translation of Words in Mark | The wording PapiVax has no meaning in a foreign language. |
Goods and Services | Bacteriological research; Biochemical research and development; Biological research; Biotechnology research; Chemical analysis; Chemical analysis services; Chemical research; Chemist services; Consulting services for others in the field of design, planning, and implementation project management of pharmaceutical trials and clinical trials; Consulting services in the field of industrial engineering; Cosmetics research for others; Culturing of cells for others for scientific research purposes; Custom design and development of chemical reagents and biochemical assays; Medical research; Pharmaceutical research services; Product quality evaluation; Product quality testing; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Rental of laboratory apparatus and instruments; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific laboratory services; Scientific research; Technical consulting in the field of pharmaceutical studies; Technical writing |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, February 16, 2023 |
Primary Code | 042 |
First Use Anywhere Date | Wednesday, September 29, 2021 |
First Use In Commerce Date | Wednesday, September 29, 2021 |
Party Name | PAPIVAX BIOTECH INC. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Taipei City 100 TW |
Party Name | PAPIVAX BIOTECH INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Taipei City 100 TW |
Event Date | Event Description |
Tuesday, February 6, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, February 6, 2024 | PUBLISHED FOR OPPOSITION |
Wednesday, January 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, January 3, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, December 25, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Sunday, December 24, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Sunday, December 24, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, October 16, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, October 16, 2023 | NON-FINAL ACTION E-MAILED |
Monday, October 16, 2023 | NON-FINAL ACTION WRITTEN |
Monday, October 16, 2023 | ASSIGNED TO EXAMINER |
Friday, February 17, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Thursday, February 16, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, January 21, 2023 | NEW APPLICATION ENTERED |